Welcome to our dedicated page for Usana Health Sciences news (Ticker: USNA), a resource for investors and traders seeking the latest updates and insights on Usana Health Sciences stock.
USANA Health Sciences Inc. (NYSE: USNA) delivers science-backed nutritional supplements and personal care products through a global direct selling network. This page provides investors and industry observers with centralized access to official company announcements and market-moving developments.
Track USANA's latest press releases including quarterly financial results, product innovation announcements, executive leadership updates, and operational expansions. Our curated feed ensures timely access to filings, partnership disclosures, and strategic initiatives that shape the company's position in the health and wellness sector.
Key focus areas include regulatory milestones for nutritional products, market entry strategies in new regions, and advancements in manufacturing quality standards. All content is sourced directly from verified corporate communications to maintain accuracy and compliance with financial disclosure standards.
Bookmark this page for streamlined monitoring of USANA's business trajectory, with updates organized chronologically for efficient research. Combine this resource with Stock Titan's financial analysis tools for comprehensive investment decision support.
USANA Health Sciences reported strong financial results for Q1 2021, with a 15.5% year-over-year increase in net sales to $308.0 million and a 17.9% rise in diluted EPS to $1.45.
The company repurchased 721,000 shares for $69.5 million and raised its 2021 outlook for net sales and diluted EPS. Active customers grew 7.7% to 617,000, showing strong demand across all regions, particularly in Asia Pacific.
USANA has launched a comprehensive Environmental, Social, and Governance (ESG) program aimed at aligning its business strategies with sustainability and corporate values. This initiative, overseen by the Sustainability Committee, focuses on two main pillars: Planet and People. Key environmental efforts include renewable energy, sustainable packaging, and responsible sourcing. USANA aims to boost diversity, equity, and community engagement through various programs. The company emphasizes this ESG commitment as vital for the long-term well-being of both the planet and the USANA community.
The recent insights from Kevin Guest, CEO of USANA (NYSE: USNA), emphasize the importance of mentorship during challenging times. In a discussion, Guest outlines four strategic steps for finding a mentor, highlighting the need to identify desired qualities, approach potential mentors courageously, and share personal goals. He credits his own success to mentorship from influential figures like Denis Waitley and has committed to philanthropy, donating book proceeds to feed children. The message underscores mentorship as a vehicle for personal and professional growth.
USANA Health Sciences, Inc. (NYSE:USNA) will release its first quarter results on April 27, 2021, post-market. A detailed "Management Commentary, Results and Outlook" will follow on their website. Additionally, a conference call is scheduled for April 28, 2021, at 11:00 a.m. Eastern Time, for analysts and institutional investors to discuss the results. USANA specializes in high-quality nutritional supplements, healthy foods, and personal care products distributed across multiple international markets.
USANA, the Cellular Nutrition Company, has partnered with USA Swimming as its Official Multivitamin, enhancing its presence in the U.S. This multi-year partnership will provide USA Swimming athletes with essential nutritional products and knowledge about multivitamins. USANA aims to support athletic performance and health, emphasizing its commitment to quality nutrition. The partnership is part of USANA's expansion into summer sports, complementing its established presence in winter sports.
On March 17, 2021, Kevin Guest, CEO of USANA Health Sciences, shared insights on overcoming pandemic challenges through the "3Rs": resilience, recalibration, and relationships. He emphasized the importance of recognizing personal resilience developed during this time and the necessity of aligning life with core values. Guest highlighted the significance of nurturing relationships which have grown more crucial during the pandemic. His book, All the Right Reasons, aims to support those navigating these challenges, promoting kindness and harmony.
USANA Health Sciences reported a strong fiscal Q4 and full-year 2020 performance. Q4 net sales climbed 14.5% YoY to $310.5 million, with diluted EPS rising 32.6% to a record $1.87. For the full year, net sales reached $1.135 billion, up 7%, and diluted EPS hit $5.86, a 32.9% increase. The company provided initial 2021 guidance for net sales between $1.21 to $1.27 billion and diluted EPS of $6.00 to $6.45. Additionally, a new share repurchase authorization of $150 million was approved. The company remains optimistic about future growth despite ongoing pandemic challenges.
FAQ
What is the current stock price of Usana Health Sciences (USNA)?
What is the market cap of Usana Health Sciences (USNA)?
